MS is more common farther from the equator: a review

Credibility

Interest

Share:1 min read

Key Takeaway

This review describes why MS is more common farther from the equator, but it does not establish the cause.

What They Found

MS is more common farther from the equator, according to studies discussed in the review. Farther from the equator, vitamin D levels tend to fall while melatonin levels tend to rise. Melatonin is a hormone the body makes in darkness. Yet northern countries have high MS rates despite higher melatonin levels. The authors discuss how sunlight, darkness, and supplements might affect these patterns, but they do not test a treatment.

Who Should Care and Why

This review draws on earlier MS research rather than studying a new group of people. It focuses on MS rates in places with different amounts of sunlight. It also discusses vitamin D, which the skin makes after sun exposure. The authors consider how darkness affects melatonin levels. The review may interest people with MS who have heard claims about sunlight or supplements.

Important Considerations

You cannot tell from this review whether changing your sunlight exposure would improve MS. The authors suggest possible treatments, but they do not test them here. The abstract does not give the number of studies reviewed or people included.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Living with MS

Article Topics:

MSlatitudemelatoninmultiple sclerosisvitamin D

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Proceedings of the National Academy of Sciences of the United States of America often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News